Cargando…
Case Report: Chimeric Antigen Receptor T Cells Induced Late Severe Cytokine Release Syndrome
BACKGROUND: Severe cytokine release syndrome (sCRS) has emerged as an adverse complication in the early period of chimeric antigen receptor T cell (CART) therapy, while whether sCRS occurs in the late period remains unknown. Here, we reported two patients with late sCRS. CASE PRESENTATION: Case 1 wa...
Autores principales: | He, Jinping, Xu, Na, Zhou, Hongsheng, Zhou, Ya, Wu, Di, Zhao, Ruochong, Lin, Tong, Xu, Ju, Cao, Rui, Li, Peng, Liu, Qifa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198280/ https://www.ncbi.nlm.nih.gov/pubmed/35719984 http://dx.doi.org/10.3389/fonc.2022.893928 |
Ejemplares similares
-
Chimeric Antigen Receptors for T-Cell Malignancies
por: Scherer, Lauren D., et al.
Publicado: (2019) -
Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment
por: Yan, Zhiling, et al.
Publicado: (2021) -
Cardiovascular effects associated with chimeric antigen receptor T cell therapy in cancer patients: A meta-analysis
por: Chen, Li-Rong, et al.
Publicado: (2022) -
Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse
por: Ding, Lijuan, et al.
Publicado: (2021) -
Chimeric antigen receptor T-cell therapy for T-ALL and AML
por: Wei, Wenwen, et al.
Publicado: (2022)